Qingdao Baheal Medical INC. (SHE:301015)
China flag China · Delayed Price · Currency is CNY
23.71
-1.11 (-4.47%)
Nov 17, 2026, 3:04 PM CST

SHE:301015 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Revenue
7,0987,5078,0948,2567,5107,052
Revenue Growth
-6.34%-7.26%-1.96%9.94%6.50%19.94%
Gross Profit
2,7002,7662,8662,7512,0841,774
Operating Income
520.28723.41981.911,053712.6614.75
Net Income
237.85474.69691.59712.06502.09421.64
Earnings Per Share
0.450.891.281.330.960.85
EPS Growth
-53.31%-30.47%-3.76%38.54%12.94%46.55%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Jan '22
Brand Operation Business Segment
5,6245,5595,0923,7002,905
Pharmaceutical Wholesale and Distribution Business Division
1,4582,1362,7743,4343,706
Retail Business Segment
397.66373.3360.02359.71418.6
Unallocated Other Operating Income
26.6726.0329.9615.1922
Total
7,5078,0948,2567,5107,052

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Investments
2,2092,4021,5121,3721,0751,317
Total Debt
3,8853,3802,3851,4551,3381,226
Net Cash (Debt)
-1,676-978.05-872.59-82.51-262.7190.77
Net Cash Growth
------
Net Cash Per Share
-3.19-1.83-1.61-0.15-0.500.18

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Cash Flow
509.48934.45813.85799.5305.75181.3
Capital Expenditures
-219.14-288.93-303.99-185.49-105.32-27.49
Free Cash Flow
290.34645.52509.86614.01200.43153.81
Free Cash Flow Growth
-48.91%26.61%-16.96%206.34%30.31%-

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Gross Margin
38.05%36.84%35.41%33.32%27.75%25.16%
Operating Margin
7.33%9.64%12.13%12.75%9.49%8.72%
Pretax Margin
5.89%9.63%11.94%12.45%8.90%8.02%
Profit Margin
3.35%6.32%8.54%8.63%6.69%5.98%
FCF Margin
4.09%8.60%6.30%7.44%2.67%2.18%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Dividend Per Share
0.5710.5710.762-0.7620.667
Dividend Per Share Growth
-25.07%-25.07%--14.24%-
Dividend Yield
2.41%2.42%3.15%-3.20%2.20%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
PE Ratio
52.3826.1318.4026.4424.9337.74
Forward PE
22.7716.5013.2725.0521.5333.48
P/FCF Ratio
43.5019.2224.9630.6762.46103.45
PS Ratio
1.781.651.572.281.672.26